Adherence and outcomes of patients prescribed dabigatran (Pradaxa) in routine clinical practice.
about
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsHypersensitivity reactions to modern antiplatelet and anticoagulant drugs.Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort studyWarfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.Target-specific oral anticoagulants and the hospitalist.Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data.Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies.Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study.Adherence to long-term anticoagulation treatment, what is known and what the future might hold.Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation.Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
P2860
Q33730353-10B8A3EE-C9B4-49B0-A73C-8B70F8742E25Q34670994-909FA28E-86DF-4EC3-88F8-7887770496F7Q36085794-39B2EBCC-2D74-40F8-BFC4-7366FD9AEF36Q38262325-CCC8B8D9-C1F9-400C-BABC-7390A1537341Q38307541-80D25E51-3814-4C5E-8307-7B5410E9BE47Q38602280-8CDDD9B5-33F5-42C7-84AC-A486FD7EF387Q38653946-8BB96709-0794-4A13-81A8-B85A67058B2AQ38655829-4BDD8583-D171-49B5-A2D5-F3469BE6331BQ38655951-8A2EC739-F5EF-4ACC-9AE1-578C8AD87281Q38833151-BF59CE9B-0692-4D3E-94E1-1E79E1E64F3DQ38903357-15221F5A-24EE-4805-A1A0-20144717B201Q38991392-409F1298-7802-4387-9FE3-6338697F4F3CQ39041243-182FB552-87EE-4723-A3AB-D5A65EFCEA73Q43630565-081D7EC2-2C5F-4903-9C48-AD9674AFBF84Q47803775-333D4118-55B6-4370-BD9F-A9B77049BC90
P2860
Adherence and outcomes of patients prescribed dabigatran (Pradaxa) in routine clinical practice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Adherence and outcomes of pati ...... in routine clinical practice.
@en
Adherence and outcomes of patients prescribed dabigatran
@nl
type
label
Adherence and outcomes of pati ...... in routine clinical practice.
@en
Adherence and outcomes of patients prescribed dabigatran
@nl
prefLabel
Adherence and outcomes of pati ...... in routine clinical practice.
@en
Adherence and outcomes of patients prescribed dabigatran
@nl
P2093
P2860
P356
P1476
Adherence and outcomes of pati ...... in routine clinical practice.
@en
P2093
K De Silva
S Jayathissa
P2860
P304
P356
10.1111/IMJ.12370
P577
2014-03-01T00:00:00Z